Insider · CIK 0001464568
Julia A Houston
Files at EFX (EQUIFAX INC). First filing Nov 17, 2023, latest Nov 21, 2023.
In brief
Julia A Houston files SEC Form 4 as officer at EFX (EQUIFAX INC). Since Nov 17, 2023, Julia A Houston has reported 0 open-market buys worth $0 and 2 open-market sells worth $4.7M, the latest filed on Nov 21, 2023.
A track record needs three past buys with six months of prices behind them; Julia A Houston has 0, so none is measured yet.
The newest scored trade: sold $417k of EFX on Nov 20, 2023, filed Nov 21, 2023, scored 31 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EFX: EQUIFAX INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | EQUIFAX INC | $417k 2,000 shares | -19% | +29% from low-12% from high | |
| 40Moderate | EQUIFAX INC | $4.3M 21,485 shares | -67% | +22% from low-16% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 15, 2023 | EFX EQUIFAX INC | 23,485 0.02% of outstanding | $4.6M | Nov 15, 2023 | none |
Transactions
Every row this insider has filed, 29 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | EFX EQUIFAX INC | AGrant or award Common Stock | +11,152 | $0.00 | $0 | 28,598 | Feb 27, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | AGrant or award Common Stock | +4,119 | $0.00 | $0 | 20,060 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | FTax withholding Common Stock | -2,614 | $202.71 | $530k | 17,446 | Feb 12, 2026 |
| Nov 14, 2025 | EFX EQUIFAX INC | FTax withholding Common Stock | -260 | $204.86 | $53k | 15,927 | Nov 18, 2025 |
| May 1, 2025 | EFX EQUIFAX INC | AGrant or award Common Stock | +720 | $0.00 | $0 | 16,163 | May 5, 2025 |
| May 1, 2025 | EFX EQUIFAX INC | AGrant or award Stock Option/Right to Buyderivative | +2,312 | $0.00 | $0 | 2,312 | May 5, 2025 |
| Feb 11, 2025 | EFX EQUIFAX INC | AGrant or award Common Stock | +1,865 | $0.00 | $0 | 16,830 | Feb 13, 2025 |
| Feb 11, 2025 | EFX EQUIFAX INC | FTax withholding Common Stock | -1,396 | $253.00 | $353k | 15,434 | Feb 13, 2025 |
| Feb 10, 2025 | EFX EQUIFAX INC | AGrant or award Common Stock | +2,076 | $0.00 | $0 | 14,965 | Feb 12, 2025 |
| Feb 10, 2025 | EFX EQUIFAX INC | AGrant or award Stock Option/Right to Buyderivative | +6,670 | $0.00 | $0 | 6,670 | Feb 12, 2025 |
| Nov 20, 2023 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -118 | $205.36 | $24k | 10,616 | Nov 21, 2023 |
| Nov 20, 2023 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -215 | $209.81 | $45k | 10,401 | Nov 21, 2023 |
| Nov 20, 2023 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -255 | $207.91 | $53k | 10,146 | Nov 21, 2023 |
| Nov 20, 2023 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -264 | $206.85 | $55k | 9,882 | Nov 21, 2023 |
| Nov 20, 2023 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -1,148 | $209.13 | $240k | 8,734 | Nov 21, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +4,326 | $121.35 | $525k | 15,060 | Nov 17, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +6,238 | $127.37 | $795k | 21,298 | Nov 17, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +3,378 | $134.58 | $455k | 24,676 | Nov 17, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +7,543 | $138.45 | $1.0M | 32,219 | Nov 17, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -224 | $195.02 | $44k | 31,995 | Nov 17, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -265 | $196.77 | $52k | 31,730 | Nov 17, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -2,902 | $198.36 | $576k | 28,828 | Nov 17, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -10,114 | $199.02 | $2.0M | 18,714 | Nov 17, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -2,577 | $200.13 | $516k | 16,137 | Nov 17, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -5,403 | $201.03 | $1.1M | 10,734 | Nov 17, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -4,326 | $0.00 | $0 | 0 | Nov 17, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -6,238 | $0.00 | $0 | 0 | Nov 17, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -3,378 | $0.00 | $0 | 0 | Nov 17, 2023 |
| Nov 15, 2023 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -7,543 | $0.00 | $0 | 0 | Nov 17, 2023 |
Questions about Julia A Houston
Answered from the filings on this page, as of the latest one.
Is Julia A Houston buying or selling?
Not in the last 12 months. Julia A Houston's latest open-market trade on SEC Form 4 was sold $417k of EFX on Nov 20, 2023.
How did Julia A Houston's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Julia A Houston has 0.
Where does Julia A Houston file Form 4?
Julia A Houston has filed Form 4 at EFX (EQUIFAX INC) as EVP, Strategy & Mktg Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.